Ginny L. Weibel

1.0k total citations
13 papers, 828 citations indexed

About

Ginny L. Weibel is a scholar working on Surgery, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Ginny L. Weibel has authored 13 papers receiving a total of 828 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Surgery, 7 papers in Molecular Biology and 5 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Ginny L. Weibel's work include Cholesterol and Lipid Metabolism (11 papers), Peroxisome Proliferator-Activated Receptors (6 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers). Ginny L. Weibel is often cited by papers focused on Cholesterol and Lipid Metabolism (11 papers), Peroxisome Proliferator-Activated Receptors (6 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers). Ginny L. Weibel collaborates with scholars based in United States. Ginny L. Weibel's co-authors include George H. Rothblat, Eric T. Alexander, Daniel J. Rader, Jeffrey T. Billheimer, Michael C. Phillips, Sissel Lund‐Katz, Michelle R. Joshi, Phu Duong, Margarita de la Llera-Moya and Denise Drazul‐Schrader and has published in prestigious journals such as Journal of Biological Chemistry, Endocrinology and Arteriosclerosis Thrombosis and Vascular Biology.

In The Last Decade

Ginny L. Weibel

13 papers receiving 816 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ginny L. Weibel United States 12 565 331 286 196 145 13 828
Emi Yakushiji Japan 16 381 0.7× 193 0.6× 289 1.0× 184 0.9× 165 1.1× 26 814
Jeffery T. Billheimer United States 7 448 0.8× 297 0.9× 224 0.8× 144 0.7× 88 0.6× 8 818
C. Justin Cooke Poland 10 476 0.8× 386 1.2× 199 0.7× 124 0.6× 121 0.8× 12 906
Shunichi Takiguchi Japan 17 383 0.7× 190 0.6× 272 1.0× 166 0.8× 150 1.0× 32 854
Jayraz Luchoomun United States 13 346 0.6× 205 0.6× 280 1.0× 132 0.7× 99 0.7× 17 764
Changting Haudenschild United States 8 424 0.8× 301 0.9× 237 0.8× 93 0.5× 146 1.0× 11 728
Menno Vergeer Netherlands 11 518 0.9× 437 1.3× 164 0.6× 164 0.8× 71 0.5× 15 869
Tomohiro Komatsu Japan 16 320 0.6× 177 0.5× 212 0.7× 114 0.6× 125 0.9× 46 689
Gregory Brubaker United States 14 481 0.9× 216 0.7× 407 1.4× 104 0.5× 183 1.3× 24 876
Marisa Viñals Spain 10 398 0.7× 175 0.5× 332 1.2× 132 0.7× 115 0.8× 13 873

Countries citing papers authored by Ginny L. Weibel

Since Specialization
Citations

This map shows the geographic impact of Ginny L. Weibel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ginny L. Weibel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ginny L. Weibel more than expected).

Fields of papers citing papers by Ginny L. Weibel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ginny L. Weibel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ginny L. Weibel. The network helps show where Ginny L. Weibel may publish in the future.

Co-authorship network of co-authors of Ginny L. Weibel

This figure shows the co-authorship network connecting the top 25 collaborators of Ginny L. Weibel. A scholar is included among the top collaborators of Ginny L. Weibel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ginny L. Weibel. Ginny L. Weibel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Weibel, Ginny L., Denise Drazul‐Schrader, Debra K. Shivers, et al.. (2013). Importance of Evaluating Cell Cholesterol Influx With Efflux in Determining the Impact of Human Serum on Cholesterol Metabolism and Atherosclerosis. Arteriosclerosis Thrombosis and Vascular Biology. 34(1). 17–25. 44 indexed citations
2.
Lund‐Katz, Sissel, Nicholas N. Lyssenko, Margaret Nickel, et al.. (2013). Mechanisms Responsible for the Compositional Heterogeneity of Nascent High Density Lipoprotein. Journal of Biological Chemistry. 288(32). 23150–23160. 32 indexed citations
3.
Weibel, Ginny L., Michelle R. Joshi, W. Gray Jerome, et al.. (2011). Cytoskeleton disruption in J774 macrophages: Consequences for lipid droplet formation and cholesterol flux. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1821(3). 464–472. 17 indexed citations
4.
Xing, Yewei, George H. Rothblat, Sandhya Sankaranarayanan, et al.. (2011). Aldosterone Production in Human Adrenocortical Cells Is Stimulated by High-Density Lipoprotein 2 (HDL2) through Increased Expression of Aldosterone Synthase (CYP11B2). Endocrinology. 152(3). 751–763. 25 indexed citations
5.
Parathath, Saj, Snjezana Doğan, Liang Guo, et al.. (2011). Rat Carboxylesterase ES-4 Enzyme Functions as a Major Hepatic Neutral Cholesteryl Ester Hydrolase. Journal of Biological Chemistry. 286(46). 39683–39692. 4 indexed citations
6.
Weibel, Ginny L., Sara A. Hayes, Michael C. Phillips, et al.. (2011). Novel In Vivo Method for Measuring Cholesterol Mass Flux in Peripheral Macrophages. Arteriosclerosis Thrombosis and Vascular Biology. 31(12). 2865–2871. 14 indexed citations
7.
Sankaranarayanan, Sandhya, Margarita de la Llera-Moya, Denise Drazul‐Schrader, et al.. (2010). Importance of macrophage cholesterol content on the flux of cholesterol mass. Journal of Lipid Research. 51(11). 3243–3249. 24 indexed citations
8.
Weibel, Ginny L., Michelle R. Joshi, Cong Wei, et al.. (2009). 15(S)-Lipoxygenase-1 associates with neutral lipid droplets in macrophage foam cells: evidence of lipid droplet metabolism. Journal of Lipid Research. 50(12). 2371–2376. 15 indexed citations
9.
Alexander, Eric T., Ginny L. Weibel, Michelle R. Joshi, et al.. (2009). Macrophage Reverse Cholesterol Transport in Mice Expressing ApoA-I Milano. Arteriosclerosis Thrombosis and Vascular Biology. 29(10). 1496–1501. 48 indexed citations
10.
Weibel, Ginny L., Michelle R. Joshi, Eric T. Alexander, et al.. (2009). Overexpression of Human 15( S )-Lipoxygenase-1 in RAW Macrophages Leads to Increased Cholesterol Mobilization and Reverse Cholesterol Transport. Arteriosclerosis Thrombosis and Vascular Biology. 29(6). 837–842. 21 indexed citations
11.
Duong, Phu, Ginny L. Weibel, Sissel Lund‐Katz, George H. Rothblat, & Michael C. Phillips. (2008). Characterization and properties of preβ-HDL particles formed by ABCA1-mediated cellular lipid efflux to apoA-I. Journal of Lipid Research. 49(5). 1006–1014. 79 indexed citations
12.
Rader, Daniel J., Eric T. Alexander, Ginny L. Weibel, Jeffrey T. Billheimer, & George H. Rothblat. (2008). The role of reverse cholesterol transport in animals and humans and relationship to atherosclerosis. Journal of Lipid Research. 50. S189–S194. 462 indexed citations
13.
Weibel, Ginny L., Eric T. Alexander, Michelle R. Joshi, et al.. (2007). Wild-Type ApoA-I and the Milano Variant Have Similar Abilities to Stimulate Cellular Lipid Mobilization and Efflux. Arteriosclerosis Thrombosis and Vascular Biology. 27(9). 2022–2029. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026